PJT PARTNERS INC - A (PJT)

US69343T1079 - Common Stock

159.105  +2.06 (+1.31%)

PJT PARTNERS INC - A

NYSE:PJT (12/24/2024, 11:55:37 AM)

159.105

+2.06 (+1.31%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorFinancials
GICS IndustryCapital Markets
GICS SubIndustryInvestment Banking & Brokerage
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%19.23%
Sales Q2Q%17.23%
CRS91.19
6 Month45.53%
Overview
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)02-04 2025-02-04/amc
Ins Owners7.87%
Inst Owners87.69%
Market Cap3.79B
Shares23.79M
PE39.19
Fwd PE29.03
Dividend Yield0.65%
Analysts47.69
Short Float %6.35%
Short Ratio6.22
IPO09-18 2015-09-18
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

PJT Daily chart

Company Profile

PJT Partners, Inc. is a holding company, which engages in the provision of advisory-investment solutions. The company is headquartered in New York City, New York and currently employs 1,012 full-time employees. The company went IPO on 2015-09-18. The firm provides independent advice coupled with client service. The firm advises clients on transactions, including mergers and acquisitions (M&A), spin-offs, activism defense, contested M&A, joint ventures, minority investments and divestitures. Additionally, it advises private and public company boards and management teams on strategies for building investor relationships with a focus on shareholder engagement; complex investor matters; environmental, social and governance (ESG) transition solutions; and other critical strategic, governance and shareholder matters. Its restructuring and special situations business provides advisory in financial restructuring and reorganization, liability management, distressed M&A and Chapter 11 matters. The Company’s global alternative asset advisory and fundraising business provides private fund advisory and fundraising services for a diverse range of investment strategies.

Company Info

PJT PARTNERS INC - A

280 Park Ave Fl 16th

New York City NEW YORK 10017

P: 12123647800

CEO: Paul J. Taubman

Employees: 1012

Website: https://pjtpartners.com/

PJT News

News Image12 days ago - BloombergMitel Weighs Restructuring as Debt at Deeply Distressed Levels

Mitel Networks is working with a cadre of advisers as the telecommunications firm looks to restructure its debt, according to people familiar with the situation.

ChartMill News Image18 days ago - ChartmillExploring NYSE:PJT's quality characteristics.

Why PJT PARTNERS INC - A (NYSE:PJT) qualifies as a quality stock.

News Imagea month ago - PJT Partners Inc.PJT Partners Inc. to Present at the Goldman Sachs 2024 Financial Services Conference on December 11
News Image2 months ago - BloombergAdvent Mulls €5 Billion Sale of Generic Drugmaker Zentiva

Buyout firm Advent International is considering the sale of generic drugmaker Zentiva, in a deal that could value the former Sanofi unit at about €5 billion ($5.4 billion), according to people familiar with the matter.

News Image2 months ago - PJT Partners Inc.PJT Partners Inc. Reports Third Quarter and Nine Months 2024 Results
News Image2 months ago - BloombergKKR’s Selecta Taps Advisers to Deal With Upcoming Maturities

KKR & Co Inc.-owned Selecta Group BV has hired advisers to help it deal with upcoming maturities, according to people familiar with the matter.

PJT Twits

Here you can normally see the latest stock twits on PJT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example